The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure - Wikidata - awgldk - TriplyDB

The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure

The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure

http://www.wikidata.org/entity/Q34361702

about

Discharge planning from hospital Discharge planning from hospital to home Assessing the Quality and Comparative Effectiveness of Team-Based Care for Heart Failure: Who, What, Where, When, and How Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis Collaborative pharmaceutical care in an Irish hospital: uncontrolled before-after study.Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial.Impact of electronic medication reconciliation interventions on medication discrepancies at hospital transitions: a systematic review and meta-analysis The potential role of clinical pharmacy services in patients with cardiovascular diseases Hospital-based medication reconciliation practices: a systematic review Can municipality-based post-discharge follow-up visits including a general practitioner reduce early readmission among the fragile elderly (65+ years old)? A randomized controlled trial.Protocol-Driven Allied Health Post-Discharge Transition Clinic to Reduce Hospital Readmissions in Heart Failure.Automated Communication Tools and Computer-Based Medication Reconciliation to Decrease Hospital Discharge Medication Errors.Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis.Pharmacist-involved care for patients with heart failure and acute coronary syndrome: a systematic review with qualitative and quantitative meta-analysis.Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure.Nurse interventions to improve medication adherence among discharged older adults: a systematic review.Impact of a Pharmacist-Managed Heart Failure Postdischarge (Bridge) Clinic for Veterans.Impact of medication reconciliation at discharge on continuity of patient care in France.Medication reconciliation at admission and discharge: an analysis of prevalence and associated risk factors.Communication between community and hospital pharmacists: impact on medication reconciliation at admission.Effects of multidisciplinary teams and an integrated follow-up electronic system on clinical pharmacist interventions in a cancer hospital.An audit of adherence to heart failure guidelines in an Australian hospital: A pharmacist perspective.Pharmacist-led intervention in the multidisciplinary team approach optimizes heart failure medication.Access to Medical Records' Impact on Community Pharmacist-Delivered Medication Therapy Management: A Pilot From the Medication Safety Research Network of Indiana (Rx-SafeNet).Discharge counseling for patients with heart failure or myocardial infarction: a best practices model developed by members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network based on the Hospital to Home (H2H) In A Review of the Role of the Pharmacist in Heart Failure Transition of Care.Current perspectives on the role of the pharmacist in heart failure management.The impact of pharmacists-led medicines reconciliation on healthcare outcomes in secondary care: A systematic review and meta-analysis of randomized controlled trials.Impact of discharge medication counseling in the cardiology unit of a tertiary hospital in Brazil: A randomized controlled trial.A Description of Patient and Provider Experience and Clinical Outcomes After Heart Failure Shared Medical Appointment.

P2860

Q24186357-59B4D22E-61E4-4F2A-9195-94A7ECA3A2D8 Q24201776-E2EBDE98-6D78-4EEC-AAF1-62C8B055AA62 Q27012929-C9351784-FE02-4283-B531-ED3DECEFF33D Q28066489-DE7EAABC-7261-4C1B-9CD9-E4FF9142C8D8 Q33834574-DEC3571C-6861-4157-92B8-4257C5D60C45 Q34485107-C8660265-30F3-4C4D-B51C-33FB10F99334 Q36109627-1549F82A-C99C-4B2E-A9AB-8EA34787F02A Q36305124-5EB08CE3-C97D-42E7-ABE1-7ED9B8FB34AC Q36619572-9A9655E8-29EB-4B25-8865-13852A4AFE3F Q36806284-683B1BC3-2996-406A-9AF1-6AD8926319CC Q36836393-1815CCC5-1C45-4F2B-9330-503116D5FE8E Q37108964-E3B1ACDF-B639-4A91-A9A3-6AD6F288808D Q38749461-67575B25-4048-439C-8269-3DD4065B0809 Q38765511-EBD8973C-6F4C-4BA3-B5A9-4FC47A525B97 Q39148915-A671828C-4FE9-4481-A81D-8D5C98AF27EA Q39311339-FCF84603-9AC3-4A2A-81A7-5A7BB2B0D939 Q39378892-D6F07421-2139-40B9-999E-C04D5E5A8589 Q39587325-D10F6D97-946F-483B-88BB-2D93492BD611 Q40298984-1D262603-CD90-4DE9-8522-4CBD101317AF Q44847182-3502368A-0D4F-4499-A9A6-35190A709CC6 Q47666379-A1CA86E2-10A6-42BB-B541-058774E0D2EA Q48133719-5B7CBFA0-7350-4D1F-AB71-AD2F8494AB63 Q48182511-12BC4B0E-5F20-4757-ABB0-7E605197A879 Q50090469-F23DAAC2-8BFE-40BE-A5D3-54B9B41D2BBB Q50863884-C1327461-3D0A-4FDA-BEAF-D1ED014F45F6 Q52682095-09B889BE-2950-4E5B-96A7-AA0DF04B122A Q54987356-BFB13AF9-9426-4A49-AC4A-7FEF32CA194E Q55261032-846DF94B-23BA-470D-B162-C33F6C6B9DFC Q55321508-8ACB75E2-D966-4979-BC79-DBD977BFDB2A Q55354225-19CEC353-A975-4A26-9059-1843041B5943

P2860

The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure

http://www.wikidata.org/entity/Q34361702

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The effect of a clinical pharm ...... in patients with heart failure

@ast

The effect of a clinical pharm ...... in patients with heart failure

@en

The effect of a clinical pharm ...... in patients with heart failure

@nl

type

label

The effect of a clinical pharm ...... in patients with heart failure

@ast

The effect of a clinical pharm ...... in patients with heart failure

@en

The effect of a clinical pharm ...... in patients with heart failure

@nl

prefLabel

The effect of a clinical pharm ...... in patients with heart failure

@ast

The effect of a clinical pharm ...... in patients with heart failure

@en

The effect of a clinical pharm ...... in patients with heart failure

@nl

P1433

Q34361702-9C8DDE1C-C2B8-41B1-8066-9C212426667C

P1476

Q34361702-AEEBDC5E-8192-405A-A74D-0697F1357FE4

P2093

Q34361702-4011872A-8676-4C41-BECD-91C73E7532AD

Q34361702-44A06726-A6D1-40F4-AA70-8E542DD8DC4E

Q34361702-BC1E433F-704B-4E5D-AA3F-381E54E37A67

Q34361702-E38D9285-CBCA-415C-9C3B-490DD56334D1

P2860

Q34361702-06C9A3E1-5E49-4A1D-8360-61D36DF7878F

Q34361702-42478288-4E7C-4547-8FE6-98EB937A3FD6

Q34361702-5415E545-D11E-465B-BCFD-94B5DC9C0381

Q34361702-68AD0622-D36B-4428-84AD-4AC928604EE0

Q34361702-75CF3D3A-3203-4904-8656-07DE5CB4643C

Q34361702-7849320D-BF64-4634-84A3-D341960A9E9B

Q34361702-80F38425-5052-4A56-A76A-06BD13B70168

Q34361702-8CD43165-5955-475E-B968-4ABDA46FA899

Q34361702-981E8B76-2419-48F8-87FD-FDC5676A461E

Q34361702-A6BE1D00-1A90-4ECB-9FEA-58EB7A52485F

P304

Q34361702-17D769F5-6FE9-4176-835C-30AA8CC657AB

P31

Q34361702-C0A733E8-DAA5-4102-A594-38E6DE993F53

P356

Q34361702-21D42B38-80E7-4301-B123-7EF67BB4200A

P407

Q34361702-BE7FDF1B-31A3-4F33-AC85-95298654B503

P433

Q34361702-C41F75DE-2F41-4C4E-975C-130D1E70D08F

P478

Q34361702-EED53A83-AE94-41CE-A79A-9D165C599EBD

P577

Q34361702-856404EF-03B0-4BD0-A33D-CAB5A056F32F

P5875

Q34361702-3EE008A0-A568-4FCD-AC82-6A21E1252A21

P698

Q34361702-2368FA8C-E45E-45A1-86E1-338414763BF1

P921

Q34361702-9441FCB1-F00B-486A-95B1-E32B50880FCA

Q34361702-B366D9AD-A74E-4C96-B143-715AF277B43D

P932

Q34361702-BDE51CF5-C8C6-46ED-87AA-BC430A574F5F

P356

S11096-010-9433-6

P1433

International Journal of Clinical Pharmacy

P1476

The effect of a clinical pharm ...... in patients with heart failure

@en

P2093

Albert W Lenderink

http://www.w3.org/2001/XMLSchema#string

Jos W M G Widdershoven

http://www.w3.org/2001/XMLSchema#string

Patricia M L A van den Bemt

http://www.w3.org/2001/XMLSchema#string

Rixt Nynke Eggink

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for enhancing medication adherence

Medical errors related to discontinuity of care from an inpatient to an outpatient setting

A chronic disease score from automated pharmacy data.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the

Preventable causative factors leading to hospital admission with decompensated heart failure.

Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland.

The value of inpatient pharmaceutical counselling to elderly patients prior to discharge

Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial

Management of heart failure in The Netherlands.

Disease management programmes for older people with heart failure: crucial characteristics which improve post-discharge outcomes.

P304

759-766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11096-010-9433-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46109017

http://www.w3.org/2001/XMLSchema#string

P698

20809276

http://www.w3.org/2001/XMLSchema#string

P921

P932

2993887

http://www.w3.org/2001/XMLSchema#string